Concepedia
Statistics
Publications
8
Citations
689
H-Index
Active since
1999
Affiliations
Nippon Shinyaku (Japan)(Current)
Kyoto University
Kyoto University Hospital
Haruna Naito is an author at Nippon Shinyaku (Japan) specializing in pharmacology, oncology, and cancer pharmacology.
Publications per year
1999–2020
NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemia
Shinya Kimura, Haruna Naito, Hidekazu Segawa et al. · Blood · 2005 · 244 citations · Full text
Medicine, Oncology, Pharmacology +7
Antitumor Activity of Small Interfering RNA/Cationic Liposome Complex in Mouse Models of Cancer
Junichi Yano, Kazuko Hirabayashi, Shinichiro Nakagawa et al. · Clinical Cancer Research · 2004 · 239 citations
Pharmacy, Oncology, Pharmacology +15
Design and synthesis of 3-substituted benzamide derivatives as Bcr-Abl kinase inhibitors
Tetsuo Asaki, Yukiteru Sugiyama, Taisuke Hamamoto et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 57 citations
Pharmacy, Chemistry, Medicinal Chemistry +10
In vivo antiproliferative effect of NS-187, a dual Bcr-Abl/Lyn tyrosine kinase inhibitor, on leukemic cells harbouring Abl kinase domain mutations
Haruna Naito, Shinya Kimura, Shinya Kimura et al. · Leukemia Research · 2006 · 50 citations
Medicine, Oncology, Pharmacology +15
Structural factors contributing to the Abl/Lyn dual inhibitory activity of 3-substituted benzamide derivatives
Tatsuya Horio, Tomohiro Hamasaki, Toshihiko Inoue et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 33 citations · Full text
Pharmacy, Chemistry, Pharmacology +12
1–5 of 8